Chris Martin
Vermögen: - $ am 30.06.2026
Vermögen: - $ am 30.06.2026
Christopher Martin is currently an Independent Director at Achieve Life Sciences, Inc. since 2026, Edgewise Therapeutics, Inc. since 2025, and Oruka Therapeutics, Inc. since 2025.
Formerly, Mr. Martin was Senior Vice President-Commercial at Verona Pharma Ltd. from 2020 to 2025, Executive Director-Marketing at SK Life Science, Inc. from 2018 to 2020, and Head-Marketing at Cempra, Inc. from 2016 to 2017.
Mr. Martin completed undergraduate education at Clemson University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
-.--% | 02.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| 11.05.2026 | 0 ( -.--% ) | - $ | 30.06.2026 | |
| 05.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 19.11.2025 |
| ACHIEVE LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 11.05.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| VERONA PHARMA PLC | Corporate Officer/Principal | 01.10.2025 |
SK Life Science, Inc.
SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in contract manufacturing clinical trial materials, pharmaceutical intermediates for pharmaceutical companies | Vertrieb & Marketing | 01.05.2020 |
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Vertrieb & Marketing | 01.11.2017 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Cempra, Inc.
Cempra, Inc. Pharmaceuticals: MajorHealth Technology Operates as a holding company with interest in manufacturing pharmaceutical products | Health Technology |
Clemson University
Clemson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Verona Pharma Plc
Verona Pharma Plc Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of allergic rhinitis and other chronic respiratory diseases | Health Technology |
SK Life Science, Inc.
SK Life Science, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in contract manufacturing clinical trial materials, pharmaceutical intermediates for pharmaceutical companies | Commercial Services |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen